These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 65127)

  • 21. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter).
    Papasteriades C; Alevizaki-Harhalaki MN; Economidou J; Ikkos DG
    J Endocrinol Invest; 1984 Aug; 7(4):283-6. PubMed ID: 6594386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
    Corrales JJ; López A; Ciudad J; Mories MT; Miralles JM; Orfao A
    J Endocrinol; 1997 Dec; 155(3):491-500. PubMed ID: 9487994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of T-cell immune abnormalities in peripheral blood lymphocytes in patients with Graves' disease or hypothyroidism.
    Mulaisho C; Abdou NI; Utiger RD
    J Clin Endocrinol Metab; 1975 Aug; 41(2):266-70. PubMed ID: 1080488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological disturbances in toxic multinodular goitre and active Graves' disease.
    Kiy Y; Rezkallah-Iwasso MT; Peraçoli MT; Mota NG
    Clin Endocrinol (Oxf); 1982 Jan; 16(1):11-7. PubMed ID: 6896172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy.
    Cappelli C; Braga M; De Martino E; Castellano M; Gandossi E; Agosti B; Cumetti D; Pirola I; Mattanza C; Cherubini L; Rosei EA
    Surg Today; 2006; 36(2):125-30. PubMed ID: 16440157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total and "activated" peripheral blood T lymphocytes in patients with thyroid disorders.
    Wall JR; Gray B; Greenwoood DM
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):753-9. PubMed ID: 329626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
    Yamada T; Sato A; Komiya I; Nishimori T; Ito Y; Terao A; Eto S; Tanaka Y
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
    Wall JR; Chartier B
    J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyperthyroidism and carcinoma of the thyroid gland].
    Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V
    Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease.
    van Soestbergen MJ; van der Vijver JC; Graafland AD
    J Endocrinol Invest; 1992 Dec; 15(11):797-800. PubMed ID: 1283983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
    Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
    Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral blood B-lymphocyte abnormalities associated with hyperthyroidism of Graves' disease.
    Hsu CC; Chen Y; Patterson R
    Clin Exp Immunol; 1976 Dec; 26(3):431-40. PubMed ID: 64326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
    Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevance of cause of hyperthyroidism in determining its management.
    Veneman TF; Weymer M; Tjabbes T; van Haeften TW
    Neth J Med; 1989 Dec; 35(5-6):303-8. PubMed ID: 2635287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases.
    Laurberg P; Vestergaard H; Nielsen S; Christensen SE; Seefeldt T; Helleberg K; Pedersen KM
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2149-56. PubMed ID: 17389703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.